环氧化酶-2抑制剂的心血管风险：我们目前的状况 - Suppr

Suppr

超能文献

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

作者信息

Finckh Axel, Aronson Mark D

出版信息

Ann Intern Med. 2005 Feb 1;142(3):212-4. doi: 10.7326/0003-4819-142-3-200502010-00013.

DOI:10.7326/0003-4819-142-3-200502010-00013

PMID:15684210

Abstract

摘要

相似文献

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

Ann Intern Med. 2005 Feb 1;142(3):212-4. doi: 10.7326/0003-4819-142-3-200502010-00013.

Selective cyclooxygenase 2 inhibitors and cardiovascular events.

Arthritis Rheum. 2005 Jul;52(7):1968-78. doi: 10.1002/art.21132.

The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice.

Clin Nurse Spec. 2006 Nov-Dec;20(6):277-65. doi: 10.1097/00002800-200611000-00006.

NSAIDS and the risk of myocardial infarction: do they help or harm?

Eur Heart J. 2006 Jul;27(14):1635-6. doi: 10.1093/eurheartj/ehl090. Epub 2006 Jun 16.

COX 2 inhibitors may increase risk of heart attack.

BMJ. 2001 Sep 1;323(7311):471.

[Do selective COX-2-inhibitors increase the risk of myocardial infarction?].

Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3434-5.

Pain medications. Options may be changing.

Mayo Clin Health Lett. 2005 May;23(5):4-5.

Why do COX-2 inhibitors increase risk of cardiovascular events?

Lancet. 2002 Apr 20;359(9315):1410. doi: 10.1016/S0140-6736(02)08393-9.

Was Vioxx really that dangerous?

Time. 2005 Feb 28;165(9):52.

COX-2 selective inhibitors--important lessons learned.

Lancet. 2005;365(9458):449-51. doi: 10.1016/S0140-6736(05)17876-3.

引用本文的文献

C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression.

Sci Rep. 2019 Dec 16;9(1):19161. doi: 10.1038/s41598-019-55605-w.

Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.

Inflammopharmacology. 2016 Feb;24(1):11-22. doi: 10.1007/s10787-015-0259-7. Epub 2016 Jan 9.

TAM receptor deficiency affects adult hippocampal neurogenesis.

Metab Brain Dis. 2015 Jun;30(3):633-44. doi: 10.1007/s11011-014-9636-y. Epub 2014 Dec 10.

Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.

Tumour Biol. 2013 Dec;34(6):3753-64. doi: 10.1007/s13277-013-0959-9. Epub 2013 Sep 21.

The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.

Int J Nanomedicine. 2011;6:1057-68. doi: 10.2147/IJN.S19561. Epub 2011 May 19.

Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Front Aging Neurosci. 2010 May 21;2. doi: 10.3389/fnagi.2010.00019. eCollection 2010.

Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

J Mater Sci Mater Med. 2010 Sep;21(9):2691-9. doi: 10.1007/s10856-010-4109-2. Epub 2010 Jun 10.

Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

J Mol Model. 2010 Dec;16(12):1919-29. doi: 10.1007/s00894-010-0679-7. Epub 2010 Mar 17.

The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.

PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568.

Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey.

J Gen Intern Med. 2006 Mar;21(3):245-50. doi: 10.1111/j.1525-1497.2006.00336.x. Epub 2006 Feb 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

作者信息

Finckh Axel, Aronson Mark D

出版信息

Ann Intern Med. 2005 Feb 1;142(3):212-4. doi: 10.7326/0003-4819-142-3-200502010-00013.

DOI:10.7326/0003-4819-142-3-200502010-00013

PMID:15684210

Abstract

摘要

相似文献

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

Ann Intern Med. 2005 Feb 1;142(3):212-4. doi: 10.7326/0003-4819-142-3-200502010-00013.

Selective cyclooxygenase 2 inhibitors and cardiovascular events.

Arthritis Rheum. 2005 Jul;52(7):1968-78. doi: 10.1002/art.21132.

The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice.

Clin Nurse Spec. 2006 Nov-Dec;20(6):277-65. doi: 10.1097/00002800-200611000-00006.

NSAIDS and the risk of myocardial infarction: do they help or harm?

Eur Heart J. 2006 Jul;27(14):1635-6. doi: 10.1093/eurheartj/ehl090. Epub 2006 Jun 16.

COX 2 inhibitors may increase risk of heart attack.

BMJ. 2001 Sep 1;323(7311):471.

[Do selective COX-2-inhibitors increase the risk of myocardial infarction?].

Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3434-5.

Pain medications. Options may be changing.

Mayo Clin Health Lett. 2005 May;23(5):4-5.

Why do COX-2 inhibitors increase risk of cardiovascular events?

Lancet. 2002 Apr 20;359(9315):1410. doi: 10.1016/S0140-6736(02)08393-9.

Was Vioxx really that dangerous?

Time. 2005 Feb 28;165(9):52.

COX-2 selective inhibitors--important lessons learned.

Lancet. 2005;365(9458):449-51. doi: 10.1016/S0140-6736(05)17876-3.

引用本文的文献

C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression.

Sci Rep. 2019 Dec 16;9(1):19161. doi: 10.1038/s41598-019-55605-w.

Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.

Inflammopharmacology. 2016 Feb;24(1):11-22. doi: 10.1007/s10787-015-0259-7. Epub 2016 Jan 9.

TAM receptor deficiency affects adult hippocampal neurogenesis.

Metab Brain Dis. 2015 Jun;30(3):633-44. doi: 10.1007/s11011-014-9636-y. Epub 2014 Dec 10.

Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.

Tumour Biol. 2013 Dec;34(6):3753-64. doi: 10.1007/s13277-013-0959-9. Epub 2013 Sep 21.

The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.

Int J Nanomedicine. 2011;6:1057-68. doi: 10.2147/IJN.S19561. Epub 2011 May 19.

Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Front Aging Neurosci. 2010 May 21;2. doi: 10.3389/fnagi.2010.00019. eCollection 2010.

Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

J Mater Sci Mater Med. 2010 Sep;21(9):2691-9. doi: 10.1007/s10856-010-4109-2. Epub 2010 Jun 10.

Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

J Mol Model. 2010 Dec;16(12):1919-29. doi: 10.1007/s00894-010-0679-7. Epub 2010 Mar 17.

The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.

PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568.

Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey.

J Gen Intern Med. 2006 Mar;21(3):245-50. doi: 10.1111/j.1525-1497.2006.00336.x. Epub 2006 Feb 22.